Cleanspark’s (CLSK) “Overweight” Rating Reiterated at Cantor Fitzgerald

Дата публикации: 10-08-2026 06:00:47

Cantor Fitzgerald reiterated their overweight rating on shares of Cleanspark (NASDAQ:CLSK – Free Report) in a research note published on Friday morning,Benzinga reports. The firm currently has a $26.00 price objective on the stock. CLSK has been the topic of a number of other research reports. Maxim Group boosted their price objective on shares of […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Trulieve Cannabis’ (TRLV) Overweight Rating Reiterated at Cantor Fitzgerald	0	6.89	10-08-2026
2	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
3	Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $53.00	0	11.84	10-08-2026
4	Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler	0	8.45	10-08-2026
5	Cantor Fitzgerald Cuts PureCycle Technologies (NASDAQ:PCT) Price Target to $12.00	0	12.26	10-08-2026
6	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
7	STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
8	US Foods (NYSE:USFD) Price Target Raised to $125.00	0	13.43	10-08-2026
9	Chime Financial (NASDAQ:CHYM) Price Target Raised to $33.00	0	13.43	10-08-2026
10	Wells Fargo & Company Cuts UGI (NYSE:UGI) Price Target to $42.00	0	13	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.11. Источник: www.americanbankingnews.com.